Saama is a series c plus startup based in United States. 1 investor tracked on Brouky Intelligence. Status: acquired. Data sourced from Brouky Intelligence.
About
Saama is a clinical data and analytics company that provides a SaaS-based platform to the life sciences industry, aimed at accelerating the delivery of clinical research and drug development.
Stage
series-c-plus
Investors
1
See full investor history, risk signals & comparable companies
Brouky tracks 15,000+ startups with funding rounds, risk analysis, and AI-powered investor matching.
Subscribe to Brouky